Science Advances Sofie Lundgren Medicine and Health, University of Helsinki University of Helsinki HUS Helsingin yliopistollinen sairaala iCAN - Digital Precision Cancer Medicine HiLIFE_Helsinki

#EHA2024 started today and @DrSGandalf presenting at the YoungEHA session. Sara also just received Academy of Finland research fellow grant to continue her research with NK cells; congrats Sara! Suomen Akatemia | Research Council of Finland European Hematology Association Translational Immunology Research Program (TRIMM) Medicine and Health, University of Helsinki iCAN - Digital Precision Cancer Medicine

Yesterday, our team celebrated the collection of 200 patient samples to our living lung cancer biobank. These valuable sample donations help us to test new drug treatments and enhance our understanding of the disease. Ilkka Ilonen, MD, Ph.D iCAN - Digital Precision Cancer Medicine #lungcancer #research

All data from our ‘MetaNK’ analysis are available at: collections.cellatlas.io/meta-nk Thanks Muzz Haniffa and Cellatlas for hosting us on the website 🙏 nature.com/articles/s4159…

Friends! I am super-excited to share our story on KLHL6 in this @BCD_aacr 📣KLHL6 targets the B-cell receptor and lymphoma mutations perturb this homeostasis! 🔓Read doi.org/10.1158/2643-3… 🪩Joint editorial in Cancer Discovery doi.org/10.1158/2159-8… 🧵Let’s go

Hi! Please check out this exciting postdoc opportunity in our laboratory: jobs.helsinki.fi/job-invite/350… The project focuses on identifying more effective immunotherapies and understanding individual mechanisms in blood cancers. Don't miss the Sep 29th deadline to join our driven team!

Can a #RandomForest learn to identify malignant cells in bone marrow #scRNAseq data? Meet me at poster 344 at #ECCB2024

Our lab is looking for a postdoctoral researcher 🧬 come join us! HRUH hematology University of Helsinki jobs.helsinki.fi/job/Helsinki-P…

Congratulations to our Scientific Director, Prof. Satu Mustjoki, and her team for being awarded the prestigious #Medix2024Prize for their significant study published in Immunity last year 👏 Join the seminar at 12 in Biomedicum or helsinki.zoom.us/j/61892612947 minervafoundation.fi/media-release-…

⚠️🚨🔬🩸 We are looking for a #PhD student who will work on #singlecell #longread research in #MPN Charité - Universitätsmedizin Berlin funded by DFG public | @[email protected] #FOR5659 Please consider applying! For a sample of previous work see my latest publication. x.com/livius_tacitus… #leukemia #immunotherapy

Thank you Finnish Society for Immunology for recognising our work! And congrats Iivo Hetemäki !

Good morning #ASH2024 ASH ☀️ Happy to finally see a work come out by the heme & transplant community Charité - Universitätsmedizin Berlin led by Dr. Jana Ihlow We show how #singlecell #genomics can be used as diagnostics post stem cell transplantation. #BMT #HSCT cell.com/med/fulltext/S…

Super excited to present our work on IL12 engineered mesothelin CAR NK cells in AML demonstrating very promising activity in preclinical models and overcoming resistance to antigen loss. @romee_lab #ASH24 #AML #NK #Immunotherapy

Honored to present my work on NK cell therapies for the treatment of #AML at #ASH2024. Grateful for my amazing HRUH hematology team for their support. Wonderfull moment to remember 🌟🎗️

Great presentations at #ASH by Hanna Duàn on NK cell responses in AML, Sofia Forstén on AML immunotherapy, Miro Nylen on Clonal hematopoiesis in lymphoma and Emmi Jokinen on WT1 TCR prediction tool. iCAN - Digital Precision Cancer Medicine Medicine and Health, University of Helsinki

Great NK cell session at #ASH Jonas Bouhlal presenting how small molecule drugs can improve NK cell cytotoxicity. Great presentations from Rizwan Romee lab in the same session. iCAN - Digital Precision Cancer Medicine Medicine and Health, University of Helsinki

Last poster session at #ASH. Salome Decombis presenting her work how stromal cells impact leukemia cells sensitivity to NK cells. Has been a great ASH, meeting friends and colleagues all over the world, looking forward next year then! iCAN - Digital Precision Cancer Medicine Medicine and Health, University of Helsinki

Yesterday I had the honor to present my work on the impact of stromal cells on leukemia sensitivity to NK cells during #ASH2024. Very grateful for my great team HRUH hematology ash.confex.com/ash/2024/webpr…

And the best poster price goes to... 🥳 Time to celebrate with some fondue! ESMO - Eur. Oncology #ESMOimmuno24 #immunooncology

Why do targeted cancer treatments fail? 🔬We found how resilient cancer cells survive therapy, reshape their environment, and drive relapse. This insight helps us tackle drug resistance and improve treatments. tinyurl.com/mu9wrsvy #CancerResearch #LungCancer Medicine and Health, University of Helsinki